WTO Price Transparency Talks Face Resistance From Developed Countries
Executive Summary
Last week the World Trade Organization’s TRIPS Council discussed transparency in medicine pricing, including R&D costs.
You may also be interested in...
New Italian Pricing Decree To Drive R&D Transparency
Following on from moves to push price transparency on to the global agenda, Italy is poised to pass a decree that would oblige companies to disclose public R&D funding.
EU Valletta Alliance Ups The Ante On Drug Pricing Transparency
EU countries should use a milestone World Health Organization resolution calling for more transparency on net medicine prices to help secure better access to medicine, says the Valletta group.
More Drug Price Disclosure In Store As WHO Delegates Pass Landmark Resolution
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: